The NIH on the ME/CFS Intramural Study -“Effort Preference”, Exhausted Immune Systems and the Crucial Male/Female Divide
The findings from a seminal (and massive) NIH intramural study done on chronic fatigue syndrome (ME/CFS) were explained during a symposium.
The Nath Intramural ME/CFS Study Pt. II: Missed Opportunities, Misreadings and… Success (?)
The NIH's in house study of chronic fatigue syndrome aka ME/CFS illuminated key factors in the disease that can be followed up on.
Amantadine – A Fatigue Reducer for Long COVID and ME/CFS?
It seems a bit odd that we haven’t heard much about amantadine (Gocovri, Symadine, and Symmetrel) in chronic fatigue syndrome (ME/CFS) or long COVID. They are, after all, the two big fatiguing diseases on the planet, and amantadine is the go-to drug for fatigue...
The Nicotine Patch Long COVID, ME/CFS and Fibromyalgia
The nicotine patch is a surprising entrant in the long COVID, ME/CFS, fibromyalgia treatment field. Find out why...
Lifting ME/CFS: The OMF’s Unique Two-Drug Clinical Trial to Begin Soon
The Open Medicine Foundations LIFT trial will explore the effects of two drugs - low dose naltrexone and Mestinon on chronic fatigue syndrome (ME/CFS)Lives Interrupted Latest Story
Bob Graybosch
Lahaina, United States
Former occupation: Resort General Manager
$1,261,443
StudyME
Enroll in the OMF’s StudyME project and help bring about a cure for ME/CFS, fibromyalgia, POTS and long COVID.
